Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Spurr Robert
U.S. President-Pharma Business at Bausch Health Companies. Filing since 18 Jan 2022.
CIK 0001543795
Company
Date
Role
Action
Shares
Amount
Of holding
BHC
Bausch Health Companies Inc.
14 Apr 2022
U.S. President-Pharma Business
Sold, plan not stated
1,595
$35.39K
1.7%
BHC
Bausch Health Companies Inc.
15 Mar 2022
U.S. President-Pharma Business
Sold, plan not stated
4,846
$107.58K
5.0%
BHC
Bausch Health Companies Inc.
2 Mar 2022
U.S. President-Pharma Business
Sold, plan not stated
1,595
$37.28K
2.4%
BHC
Bausch Health Companies Inc.
15 Feb 2022
U.S. President-Pharma Business
Sold, plan not stated
3,251
$81.34K
5.1%
BHC
Bausch Health Companies Inc.
18 Jan 2022
U.S. President-Pharma Business
Sold, plan not stated
3,251
$86.57K
4.9%
5 decisions on file.
